AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. - Wikidata - awgldk - TriplyDB

AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

http://www.wikidata.org/entity/Q37062840

about

New promises for metformin: advances in the understanding of its mechanisms of action Folate Metabolism Regulates Oligodendrocyte Survival and Differentiation by Modulating AMPKα Activity AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.Activators of AMPK: not just for type II diabetes.mTOR in Brain Physiology and Pathologies.Combination therapy of lovastatin and AMPK activator improves mitochondrial and peroxisomal functions and clinical disease in EAE model.Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia.Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia.Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancer.

P2860

Q27023545-D92EA8F6-B29A-4FA6-A6C1-E9B4F82AC7C0 Q33686995-EA0E5B6F-0626-40F9-B909-3AB50F571070 Q35826151-ECA67922-74E4-45AB-9167-E566E714CEB3 Q37373698-4D9D941B-D2FF-4C12-8E52-BD1CC5016BA0 Q38243893-B58B10A9-610B-43CC-98C2-2468C7F79587 Q38565769-568A07FE-10F1-4D61-BB0A-A69384AE719D Q47656532-C3821C21-3375-4A81-8501-2F907140B3E7 Q48451001-B0402365-21DC-47B1-A62E-10F5E2807353 Q48575097-F465331A-C05B-401D-BC9F-B481839352DB Q55267472-05E08E06-6DDD-4645-8439-7F9C1329318B

P2860

AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

http://www.wikidata.org/entity/Q37062840

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@en

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@nl

type

label

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@en

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@nl

prefLabel

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@en

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@nl

P1433

Q37062840-D8D22BB0-6706-4B93-89ED-0067198DD737

P1476

Q37062840-A591C673-6657-4622-8347-93F5AFEA9733

P2093

Q37062840-156C7100-92D4-452D-A7F1-13860F9431F4

Q37062840-27512797-1207-46F4-B696-17E023EE6DD1

Q37062840-487D1744-FDC2-4944-B445-DA9DB09E235C

Q37062840-D03C2D2F-23CA-45FF-966F-F2602C650B1B

Q37062840-D909CBA3-F8A6-4561-9CD1-E324909C1978

P2860

Q37062840-019F50AE-D214-4597-9F71-CE2A7C3F7EE2

Q37062840-0CD1A38C-2A2F-426C-941A-716DFA358DB8

Q37062840-13C52A76-E8EB-4BE3-BEA9-F75EFB88E83C

Q37062840-20141F64-A284-4203-B5E4-6DD4AA5A1D50

Q37062840-20ABF7DF-C4FD-43D4-ACD0-A9B7F239401B

Q37062840-225C7829-596E-47B6-9AAD-12551E2C1E85

Q37062840-2550D224-FC01-44D6-99DA-22FAA68721C2

Q37062840-29D2557D-C544-413C-BEDD-43FD9B4948E3

Q37062840-2C2A8BF5-3AD2-4E12-9D56-5A0413AC4F08

Q37062840-36B318FE-C819-431A-93E0-A1F6905C15F7

P304

Q37062840-5A98CE21-A80C-4580-A099-AB56F3D5E566

P31

Q37062840-36A2F434-360E-45DC-9D23-E84C401F84BF

P356

Q37062840-035615EC-CDBD-4C40-8232-B5AFFA322E5C

P407

Q37062840-F904CCDB-828C-455C-862E-5313ACC012D2

P433

Q37062840-6A226962-186F-478E-A1F4-848B0F2FD513

P478

Q37062840-27B17E2C-3377-44F1-BDDA-AC482D2F92D7

P577

Q37062840-8F94E6BB-BF34-4B32-BECE-F33EFC688DF1

P5875

Q37062840-D533D726-6D69-4095-9320-94771EC0D8AE

P698

Q37062840-74A130B9-2B09-4C20-B20F-BCD971B59B12

P921

Q37062840-5C10D0E2-09D7-416F-A0C5-9173F260CE8A

Q37062840-83E0E040-C528-45CA-A5F0-CE924E7A15FA

P932

Q37062840-E65ED3CA-4CE5-4B25-BC7F-A1F402DE5413

P356

J.AJPATH.2013.04.030

P1433

The American Journal of Pathology

P1476

AMP-activated protein kinase s ...... mmune encephalomyelitis model.

@en

P2093

Ajaib S Paintlia

http://www.w3.org/2001/XMLSchema#string

Avtar K Singh

http://www.w3.org/2001/XMLSchema#string

Inderjit Singh

http://www.w3.org/2001/XMLSchema#string

Manjeet K Paintlia

http://www.w3.org/2001/XMLSchema#string

Sarumathi Mohan

http://www.w3.org/2001/XMLSchema#string

P2860

AMPK in the brain: its roles in energy balance and neuroprotection

Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist

Remyelination protects axons from demyelination-associated axon degeneration

Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.

Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis.

AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.

P304

526-541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2013.04.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237814739

http://www.w3.org/2001/XMLSchema#string

P698

23759513

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis

oligodendrocyte

P932

3730772

http://www.w3.org/2001/XMLSchema#string